An In-Depth Analysis of Anti-Diabetic Medication Prescribing Patterns, Utilization Trends, and Patient Compliance: A Cross-Sectional Study at Santosh Medical College and Hospital, Delhi NCR
Keywords:Diabetes Mellitus, Drug Utilization Patterns, Patient Compliance, WHO Drug Prescribing Indicators, Morisky's Medication Adherence Scale, Cross-Sectional Study, Santosh Medical College and Hospital, Delhi NCR.
This cross-sectional study conducted at Santosh Medical College and Hospital in Ghaziabad, Delhi NCR, delves into the prescribing patterns, utilization trends, and patient compliance regarding anti-diabetic medications. With a focus on outpatients, the research utilizes WHO Drug Prescribing Indicators and Morisky's Medication Adherence Scale for comprehensive analysis. The demographic distribution reveals a concentration of diabetic patients in the 31 to 60 age group, emphasizing the need for targeted interventions in this productive age range. Predominant prescription of Biguanides and Sulfonylureas aligns with global guidelines, while limited use of newer drug classes prompts exploration into potential barriers. Polytherapy prevalence underscores the multifaceted nature of diabetes management. Noteworthy adherence to WHO essential drugs, generic names, and fixed-dose combinations reflects commitment to evidence-based and cost-effective practices. Morisky's scale reveals positive compliance behaviors, with education level, diabetes duration, HbA1c levels, comorbidities, and knowledge influencing adherence. The study's implications include targeted interventions for improved compliance, highlighting the intricate relationship between patient demographics, prescription practices, and medication adherence. Comparative analysis with existing literature enhances the study's generalizability, while future research opportunities aim to explore additional variables and socio-economic influences for refined strategies in diabetic patient care. The comprehensive insights provided can guide healthcare practitioners, policymakers, and researchers in optimizing diabetes management practices, fostering continuous improvement in patient outcomes and healthcare practices.